Experts Rejected for Conflict of Interest and Failure to Use Management Projections

Business Valuation UpdateVol. 8 No. 7
Legal and Court Case Update
July 2002

Access the Full Article

This article is available with a subscription to any of these products:
Already a subscriber?  Login
This article is also available for purchase. (888 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
5122 Drugs, Drug Proprietaries, and Druggists' Sundries
424210 Drugs and Druggists' Sundries Merchant Wholesalers
shareholder dissent/oppression
shareholder dispute
Gray v. Cytokine Pharmasciences, Inc.
2002 Del. Ch. LEXIS 48
April 25, 2002
US
State Court
Delaware
Court of Chancery
Jeffrey B. Davis (for Gray)<br>J. Mark Penny (for Cytokine)<br>Merrill Lynch (for Cytokine)
Lamb

Summary

The issue in this case was the fair value of the shares of PharmaSciences Inc. (PSI).

See Also

Gray v. Cytokine Pharmasciences, Inc.

Full Text of Court Cases
April 25, 2002

The issue in this case was the fair value of the shares of PharmaSciences, Inc.